REVANCE THERAPEUTICS, INC.
REVANCE THERAPEUTICS, INC. is a registered legal entity registered in United States under 001150165, and its current status with Tennessee Secretary of State is active. The company was incorporated on 27 December 2020 and lists its registered address as NASHVILLE, United States. 5 shareholders are on record for REVANCE THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Tennessee Secretary of State and was last updated on 2 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for REVANCE THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Capital World Investors, holding 14.8% — the largest recorded stake — followed by Blackrock Inc. at 10.1%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 20 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Capital World Investors | 14.8% | Tennessee Secretary of State | |
| Blackrock Inc. | 10.1% | Tennessee Secretary of State | |
| Smallcap World Fund | 9.8% | Tennessee Secretary of State | |
| Palo Alto Investors Lp | 8.1% | Tennessee Secretary of State | |
| JP Morgan Chase & Company | 7.2% | Tennessee Secretary of State |
Officers
5
The Ceo & Director of REVANCE THERAPEUTICS, INC. currently on record is Mark J. Foley; five officers are currently on record for REVANCE THERAPEUTICS, INC., filed with Tennessee Secretary of State.
The register reports 10 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at REVANCE THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
REVANCE THERAPEUTICS, INC. sits 1 level below its ultimate parent, Crown Laboratories, Inc., registered in United States. 3 subsidiaries are recorded beneath it, across 2 jurisdictions. The full chain up to Crown Laboratories, Inc. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by REVANCE THERAPEUTICS, INC.'s own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 3 subsidiaries span United States, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Crown Laboratories, Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns REVANCE THERAPEUTICS, INC.?
Five shareholders are currently on record for REVANCE THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Capital World Investors, holding 14.8% — the largest recorded stake — followed by Blackrock Inc. at 10.1%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is REVANCE THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for REVANCE THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does REVANCE THERAPEUTICS, INC. have on record?
5 shareholders are shown on record for REVANCE THERAPEUTICS, INC.. The register reports 20 in total; only the top 5 by holding are shown here.
What is REVANCE THERAPEUTICS, INC.'s company registration number?
REVANCE THERAPEUTICS, INC.'s registration number is 001150165, filed with Tennessee Secretary of State in United States. Its current status on the register is active.
Is REVANCE THERAPEUTICS, INC. still an active company?
REVANCE THERAPEUTICS, INC.'s status on Tennessee Secretary of State is listed as active.
When was REVANCE THERAPEUTICS, INC. incorporated?
REVANCE THERAPEUTICS, INC. was incorporated on 27 December 2020, according to Tennessee Secretary of State.
What is REVANCE THERAPEUTICS, INC.'s registered address?
The registered address on file for REVANCE THERAPEUTICS, INC. is NASHVILLE, United States.
Who are the officers/directors of REVANCE THERAPEUTICS, INC.?
The Ceo & Director of REVANCE THERAPEUTICS, INC. currently on record is Mark J. Foley; five officers are currently on record for REVANCE THERAPEUTICS, INC., filed with Tennessee Secretary of State. Management authority at REVANCE THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does REVANCE THERAPEUTICS, INC. have a parent company or subsidiaries?
REVANCE THERAPEUTICS, INC. sits 1 level below its ultimate parent, Crown Laboratories, Inc., registered in United States. 3 subsidiaries are recorded beneath it, across 2 jurisdictions. Those 3 subsidiaries span United States, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to REVANCE THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Tennessee Secretary of State. Zavia's monitoring API can track changes to REVANCE THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access REVANCE THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like REVANCE THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Tennessee Secretary of State and was last synced on 2 October 2026.